Td vaccine can prevent tetanus and diphtheria.
LPI (LP Information)' newest research report, the “TD Vaccine Industry Forecast” looks at past sales and reviews total world TD Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected TD Vaccine sales for 2023 through 2029. With TD Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TD Vaccine industry.
This Insight Report provides a comprehensive analysis of the global TD Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TD Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global TD Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TD Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TD Vaccine.
The global TD Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for TD Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for TD Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for TD Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key TD Vaccine players cover Sanofi, Grifols, GSK, Biological E Limited, Incepta Pharma and BB-NCIPD Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of TD Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
3-dose Series
More than 3-dose Series
Segmentation by application
TETANUS (T)
DIPITHERIA (D)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Grifols
GSK
Biological E Limited
Incepta Pharma
BB-NCIPD Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global TD Vaccine market?
What factors are driving TD Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TD Vaccine market opportunities vary by end market size?
How does TD Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global TD Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for TD Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for TD Vaccine by Country/Region, 2018, 2022 & 2029 2.2 TD Vaccine Segment by Type 2.2.1 3-dose Series 2.2.2 More than 3-dose Series 2.3 TD Vaccine Sales by Type 2.3.1 Global TD Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global TD Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global TD Vaccine Sale Price by Type (2018-2023) 2.4 TD Vaccine Segment by Application 2.4.1 TETANUS (T) 2.4.2 DIPITHERIA (D) 2.5 TD Vaccine Sales by Application 2.5.1 Global TD Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global TD Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global TD Vaccine Sale Price by Application (2018-2023) 3 Global TD Vaccine by Company 3.1 Global TD Vaccine Breakdown Data by Company 3.1.1 Global TD Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global TD Vaccine Sales Market Share by Company (2018-2023) 3.2 Global TD Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global TD Vaccine Revenue by Company (2018-2023) 3.2.2 Global TD Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global TD Vaccine Sale Price by Company 3.4 Key Manufacturers TD Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers TD Vaccine Product Location Distribution 3.4.2 Players TD Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for TD Vaccine by Geographic Region 4.1 World Historic TD Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global TD Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global TD Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic TD Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global TD Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global TD Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas TD Vaccine Sales Growth 4.4 APAC TD Vaccine Sales Growth 4.5 Europe TD Vaccine Sales Growth 4.6 Middle East & Africa TD Vaccine Sales Growth 5 Americas 5.1 Americas TD Vaccine Sales by Country 5.1.1 Americas TD Vaccine Sales by Country (2018-2023) 5.1.2 Americas TD Vaccine Revenue by Country (2018-2023) 5.2 Americas TD Vaccine Sales by Type 5.3 Americas TD Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC TD Vaccine Sales by Region 6.1.1 APAC TD Vaccine Sales by Region (2018-2023) 6.1.2 APAC TD Vaccine Revenue by Region (2018-2023) 6.2 APAC TD Vaccine Sales by Type 6.3 APAC TD Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe TD Vaccine by Country 7.1.1 Europe TD Vaccine Sales by Country (2018-2023) 7.1.2 Europe TD Vaccine Revenue by Country (2018-2023) 7.2 Europe TD Vaccine Sales by Type 7.3 Europe TD Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa TD Vaccine by Country 8.1.1 Middle East & Africa TD Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa TD Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa TD Vaccine Sales by Type 8.3 Middle East & Africa TD Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of TD Vaccine 10.3 Manufacturing Process Analysis of TD Vaccine 10.4 Industry Chain Structure of TD Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 TD Vaccine Distributors 11.3 TD Vaccine Customer 12 World Forecast Review for TD Vaccine by Geographic Region 12.1 Global TD Vaccine Market Size Forecast by Region 12.1.1 Global TD Vaccine Forecast by Region (2024-2029) 12.1.2 Global TD Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global TD Vaccine Forecast by Type 12.7 Global TD Vaccine Forecast by Application 13 Key Players Analysis 13.1 Sanofi 13.1.1 Sanofi Company Information 13.1.2 Sanofi TD Vaccine Product Portfolios and Specifications 13.1.3 Sanofi TD Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Sanofi Main Business Overview 13.1.5 Sanofi Latest Developments 13.2 Grifols 13.2.1 Grifols Company Information 13.2.2 Grifols TD Vaccine Product Portfolios and Specifications 13.2.3 Grifols TD Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Grifols Main Business Overview 13.2.5 Grifols Latest Developments 13.3 GSK 13.3.1 GSK Company Information 13.3.2 GSK TD Vaccine Product Portfolios and Specifications 13.3.3 GSK TD Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 GSK Main Business Overview 13.3.5 GSK Latest Developments 13.4 Biological E Limited 13.4.1 Biological E Limited Company Information 13.4.2 Biological E Limited TD Vaccine Product Portfolios and Specifications 13.4.3 Biological E Limited TD Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Biological E Limited Main Business Overview 13.4.5 Biological E Limited Latest Developments 13.5 Incepta Pharma 13.5.1 Incepta Pharma Company Information 13.5.2 Incepta Pharma TD Vaccine Product Portfolios and Specifications 13.5.3 Incepta Pharma TD Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Incepta Pharma Main Business Overview 13.5.5 Incepta Pharma Latest Developments 13.6 BB-NCIPD Ltd. 13.6.1 BB-NCIPD Ltd. Company Information 13.6.2 BB-NCIPD Ltd. TD Vaccine Product Portfolios and Specifications 13.6.3 BB-NCIPD Ltd. TD Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 BB-NCIPD Ltd. Main Business Overview 13.6.5 BB-NCIPD Ltd. Latest Developments 14 Research Findings and Conclusion